Brief: NGM Bio Reports Q4 Net Loss Per Share Of $0.24
17/03/2020 21:06
March 17 (Reuters) - NGM Biopharmaceuticals Inc NGM.O :
* NGM BIO REPORTS FOURTH QUARTER AND FULL YEAR 2019
FINANCIAL
RESULTS AND RECENT HIGHLIGHTS
* NGM BIOPHARMACEUTICALS - QTRLY NET LOSS PER SHARE $0.24
* NGM BIOPHARMACEUTICALS - QTRLY RELATED PARTY REVENUE FROM
COLLABORATION WITH MERCK WAS $31.1 MILLION VERSUS $47.1 MILLION
Source text for Eikon: ID:nGNX9CyV7X
Further company coverage: NGM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NGM Biopharmaceuticals
See all newsBrief: NGM Biopharmaceuticals Q4 Net Income USD -27.67 Million
Brief: NGM Bio Enters into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group
NGM Biopharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Ngm Biopharmaceuticals Says It Got Written Notice From Nasdaq Informing It Has Regained Compliance With Nasdaq Listing
Brief: NGM Bio Announces New Clinical Data From Ongoing Trial Of Ngm707 In Advanced Solid Tumors